Tirzepatide Peptide 40mg vial
Original price was: $275.00.$200.00Current price is: $200.00.
DISCLAIMER: FOR RESEARCH PURPOSES ONLY
- This product is intended strictly for use as a research chemical. It is designated for in vitro laboratory testing and experimentation only, and is not intended for human or animal consumption under any circumstances. All information provided on this website is for educational and informational purposes only. This substance is not approved for use as a drug, food, or cosmetic, and must not be misused, misbranded, or represented as such. Handling of this product is restricted to qualified, licensed professionals in controlled laboratory settings. Any bodily introduction or use outside of legal research contexts is strictly prohibited by law.
What is Tirzepatide, and how does it work?
Tirzepatide is a novel, investigational, once-weekly dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for the treatment of type 2 diabetes and obesity. It represents a significant advancement in the field of metabolic medicine due to its dual action on GIP and GLP-1 receptors, which play crucial roles in glucose and weight regulation.
Tirzepatide works by activating both the GIP and GLP-1 receptors, leading to increased insulin secretion, decreased glucagon secretion, slowed gastric emptying, and reduced appetite. This dual action contributes to improved glycemic control and expedite weight loss.
| Weekly Dose | 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, 15mg |
|---|
Related products
Reviews
There are no reviews yet